AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Dolutegravir Sodium+ Lamivudine + Tenofovovir Disoproxil Fumarate

9 registrations across 1 African market— 9 active

Markets with Dolutegravir Sodium+ Lamivudine + Tenofovovir Disoproxil Fumarate

Recent registrations

Brand / ProductMarketHolderStatusExpires
Dolutegravir+Lamivudine+Tenofovir Disoproxil Fumarate
Tablets
🇹🇿TanzaniaLAURUS LABS LIMITEDactive
Dolutegravir 50 mg, Lamivudine 300 mg and Tenofovir disoproxil fumarate 300 mg Tablet
Oral tablet
🇹🇿TanzaniaMacleods Pharmaceuticals Limitedactive
VIROPIL
Tablets
🇹🇿TanzaniaEmcure Pharmaceuticals Ltdactive
Dolutegravir+Lamivudine+Tenofovir Disoproxil Fumarate
Tablets
🇹🇿TanzaniaHetero Labs Limitedactive
Dolutegravir 50mg, Lamivudine 300mg and Tenofovir Disoproxil Fumarate Tablets 300mg
Film Coated Tablet
🇹🇿TanzaniaSHANGHAI DESANO BIO-PHARMACEUTICAL Co., LTD.,active
Dolutegravir 50mg , Lamivudine 300mg and Tenofovir Disoproxil Fumarate 300mg Tablets
Film Coated Tablet
🇹🇿TanzaniaMacleods Pharmaceuticals Limitedactive
Dolutegravir, Lamivudine and TENOFOVOR DISOPROXIL
Tablets
🇹🇿TanzaniaQuality Chemical Industries Limitedactive
Dolutegravir/Lamivudine/Tenofovir Disoproxil Fumarate
Tablet, Film-coated
🇹🇿TanzaniaSun Pharmaceutical Industries Ltdactive
Siropil
Film Coated Tablet
🇹🇿TanzaniaEmcure Pharmaceuticals Ltdactive

Dolutegravir Sodium+ Lamivudine + Tenofovovir Disoproxil Fumarate in Africa — Regulatory Overview

Dolutegravir Sodium+ Lamivudine + Tenofovovir Disoproxil Fumarate is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.